Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (266)
ZEVRA THERAPEUTICS, INC. (ZVRA)
Thompson Rahsaan — Chief Legal&Compliance
Shares
42,666
Price
$11.13
Total Value
$474.77K
Shares Held After
37,569
% of Holdings
53.2%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
40
Price
$333.23
Total Value
$13.33K
Shares Held After
50,000
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
3,095
Price
$331.43
Total Value
$1.03M
Shares Held After
50,040
% of Holdings
5.8%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
4,896
Price
$330.36
Total Value
$1.62M
Shares Held After
53,135
% of Holdings
8.4%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
7,428
Price
$329.60
Total Value
$2.45M
Shares Held After
58,031
% of Holdings
11.3%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
1,687
Price
$328.52
Total Value
$554.21K
Shares Held After
65,459
% of Holdings
2.5%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
5,226
Price
$327.39
Total Value
$1.71M
Shares Held After
67,146
% of Holdings
7.2%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
2,287
Price
$326.60
Total Value
$746.94K
Shares Held After
72,372
% of Holdings
3.1%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
341
Price
$325.60
Total Value
$111.03K
Shares Held After
74,659
% of Holdings
0.5%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
3,847
Price
$111.14
Total Value
$427.55K
Shares Held After
31,034
% of Holdings
11.0%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
9,193
Price
$110.00
Total Value
$1.01M
Shares Held After
34,881
% of Holdings
20.9%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
10,200
Price
$109.11
Total Value
$1.11M
Shares Held After
44,074
% of Holdings
18.8%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
14,696
Price
$107.97
Total Value
$1.59M
Shares Held After
54,274
% of Holdings
21.3%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
10,434
Price
$107.14
Total Value
$1.12M
Shares Held After
68,970
% of Holdings
13.1%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
3,630
Price
$106.05
Total Value
$384.96K
Shares Held After
79,404
% of Holdings
4.4%
AbCellera Biologics Inc. (ABCL)
Booth Andrew — Chief Financial Officer
Shares
37,200
Price
$10.32
Total Value
$383.90K
Shares Held After
482,800
% of Holdings
7.7%
Showing 101–150 of 266 transactions (page 3 of 6)